Longevity Health Q2 FY26 net loss narrows 0% to $1,883,290; net sales fall 21% to $395,991
Reuters2026/08/14 21:07- Longevity Health Holdings posted a GAAP net loss of USD 3.32 million for the six months ended June 30, 2026, narrowing 2%.
- Net sales fell 22% to USD 787,755, reflecting lower demand tied to increased competition in the bio-aesthetics market.
- Operating loss narrowed 39% to USD 2.05 million as total operating expenses dropped 36% to USD 2.53 million.
- Other expense widened to USD 1.26 million, driven by a USD 1.17 million increase in the contingent liability for the Puritan Settlement.
- Cash was USD 35,471 at June 30, 2026; management flagged substantial doubt about going concern and expects to seek additional financing.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Geopolitical tensions overshadowing production cuts: OPEC+ maintains quotas unchanged, paper adjustments fail to resolve physical supply dilemmas
OPEC+ major oil producers, led by Saudi Arabia and Russia, held a monthly video conference last Sunday and decided to keep the crude oil production quota for October unchanged, continuing the previous tone of stable production following a series of symbolic production increases.
No Public Money Behind El Salvador’s New Bitcoin, IMF Confirms
PetroTal forecasts FY2026 adjusted EBITDA at USD 110 million-120 million
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
Crypto prices
More
